OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,099,796 | +47.7% | 655,754 | +8.0% | 0.00% | 0.0% |
| Q2 2023 | $5,484,280 | +351.6% | 607,340 | +73.6% | 0.00% | – |
| Q1 2023 | $1,214,312 | +147089.3% | 349,946 | +3.9% | 0.00% | – |
| Q4 2022 | $825 | -99.9% | 336,899 | +2.9% | 0.00% | – |
| Q3 2022 | $903,000 | -22.8% | 327,535 | +14.0% | 0.00% | – |
| Q2 2022 | $1,169,000 | -42.2% | 287,247 | -39.5% | 0.00% | – |
| Q1 2022 | $2,023,000 | -53.0% | 474,898 | +3.2% | 0.00% | -100.0% |
| Q4 2021 | $4,308,000 | -66.4% | 460,361 | -1.1% | 0.00% | -50.0% |
| Q3 2021 | $12,823,000 | +115.7% | 465,287 | +118.9% | 0.00% | +100.0% |
| Q2 2021 | $5,946,000 | -16.3% | 212,522 | -0.8% | 0.00% | 0.0% |
| Q1 2021 | $7,107,000 | +457.8% | 214,223 | +708.4% | 0.00% | – |
| Q4 2020 | $1,274,000 | – | 26,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |